Back to search
FDAFDA · Food and drugs·Recall number D-0875-2018

Allergan Taytulla Softgel Capsules, 1 mg/20 mcg, 6x28 blister card Physicians's Sample - Not for Sale Distributed by: Allergan USA INC Irvine, CA 92612 NDC 0023-5862-28 (Blister Card) NDC 0023-5862-29 (Blister Carton) NDC 0023-5862-31 (Outer carton) UPC 300235862290

Published June 20, 2018 · Recall initiated: May 24, 2018

Summary

FDA records drug Class I recall D-0875-2018, published June 20, 2018 and initiated May 24, 2018. Recalling firm: Allergan, PLC.; Status: Terminated; Reported quantity: 168,768 blister cards (4,725,504 softgel capsules); Lot: Lot# 5620706, Exp. 05/19. Class I means a reasonable probability of serious adverse health consequences or death.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Contraceptive Tablets Out of Sequence.

What to do

Voluntary: Firm initiated · Letter

Get an email if TAYTULLA has another recall

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Brand
TAYTULLA
Manufacturer
Allergan, PLC.
Distributor
US Nationwide
UPC
300235862290
Lot
Lot# 5620706, Exp. 05/19
Risk classification
Class I
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was Allergan Taytulla Softgel Capsules, 1 mg/20 mcg, 6x28 blister card Physicians's Sample - Not for Sale Distributed by: Allergan USA INC Irvine, CA 92612 NDC 0023-5862-28 (Blister Card) NDC 0023-5862-29 (Blister Carton) NDC 0023-5862-31 (Outer carton) UPC 300235862290 recalled?

Yes. FDA published recall D-0875-2018 on June 20, 2018. Reported hazard: Contraceptive Tablets Out of Sequence.

What should I do if I have this product?

Voluntary: Firm initiated · Letter

How do I know if my unit is part of the recall?

Compare your product details with the notice. Brand: TAYTULLA. UPC: 300235862290.